December 2, 2019
Invited Commentary by Lyerly Published in The Lancet
The commentary, by Anne Drapkin Lyerly, MD, professor of social medicine and associate director of the UNC Center for Bioethics, argues that the WHO's recommendation of dolutegravir as an HIV treatment for all populations was a significant advancement in the ethical inclusion of pregnant women in biomedical research.